The FDA Removed REMS For CAR-T Cell Therapy—Now Community Providers Can Expand Access

Forefront Group 2026 Dataset

View at publisher
Authors: William H. Shrank, George Eastwood, Aaron J. Lyss, Michael T. Byrne
DOI: 10.1377/forefront.20260303.889113
Cited by: 0

Fields of Study & Subjects

CAR-T cell therapy research Biomedical Ethics and Regulation Pharmaceutical Economics and Policy

Publication details

Journal / source
Forefront Group
Publication date
9 March 2026
Language
EN
Document type
Dataset